Latest period
$753.82M
YoY change
+146.7%
5Y CAGR
+50.8%
Peak year (2025)
$723.21M
Latest annual
$723.21M
Total Liabilities history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: $723.21M
Total Liabilities growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: +146.7%
Total Liabilities history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | $723.21M | +146.7% | +$430.11M | ||
| 2024 | $293.10M | +24.5% | +$57.59M | ||
| 2023 | $235.51M | +85.8% | +$108.77M | ||
| 2022 | $126.74M | -6.4% | −$8.68M | ||
| 2021 | $135.42M | +46.0% | +$42.70M | ||
| 2020 | $92.72M | +36.4% | +$24.73M | ||
| 2019 | $67.99M | -8.0% | −$5.93M | ||
| 2018 | $73.93M | +601.0% | +$63.38M | ||
| 2017 | $10.55M | — | — |
- 2025$723.21M+146.7%
- 2024$293.10M+24.5%
- 2023$235.51M+85.8%
- 2022$126.74M-6.4%
- 2021$135.42M+46.0%
- 2020$92.72M+36.4%
- 2019$67.99M-8.0%
- 2018$73.93M+601.0%
- 2017$10.55M—
Total Liabilities values are taken from Revolution Medicines's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's latest reported total liabilities is $753.82M. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Revolution Medicines (RVMD) total liabilities totalled $723.21M – surged 146.7% year-over-year.
Across 2020–2025 (5 years), Revolution Medicines total liabilities produced a CAGR of +50.8% – with mixed annual results across the window.
2025 marks the peak total liabilities at $723.21M, with the historical low of $10.55M recorded in 2017.
Revolution Medicines Total Liabilities by Year
Revolution Medicines Total Liabilities 2025: $723.21M
In 2025, Revolution Medicines reported total liabilities of $723.21M, surged 146.7% from 2024. This figure represents the highest annual value in the available history.
Revolution Medicines Total Liabilities 2024: $293.10M
Revolution Medicines total liabilities in 2024 was $293.10M, grew 24.5% from 2023.
Revolution Medicines Total Liabilities 2023: $235.51M
2023's total liabilities for Revolution Medicines came in at $235.51M, surged 85.8% from 2022.
Revolution Medicines Total Liabilities 2022: $126.74M
Revolution Medicines posted total liabilities of $126.74M in 2022, declined 6.4% below 2021.
Revolution Medicines Total Liabilities 2021: $135.42M
Revolution Medicines total liabilities in 2021 was $135.42M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Total Liabilities
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation